Annals of the Rheumatic Diseases


ISSN: 0003-4967        年代:2004
当前卷期:Volume 63  issue suppl_2     [ 查看所有卷期 ]

年代:2004
 
     Volume 63  issue suppl_2
     Volume 63  issue 1   
     Volume 63  issue 2   
     Volume 63  issue 3   
     Volume 63  issue 4   
     Volume 63  issue 5   
     Volume 63  issue 6   
     Volume 63  issue 7   
     Volume 63  issue 8   
     Volume 63  issue 9   
     Volume 63  issue 10   
     Volume 63  issue 11   
     Volume 63  issue 12   
1. Advances in targeted therapies VI
  Annals of the Rheumatic Diseases,   Volume  63,   Issue  suppl_2,   2004,   Page  1-1

F CBreedveld,   J RKalden,   J SSmolen,  

Preview

2. Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004
  Annals of the Rheumatic Diseases,   Volume  63,   Issue  suppl_2,   2004,   Page  2-12

D EFurst,   F CBreedveld,   J RKalden,   J SSmolen,   G RBurmester,   J W JBijlsma,   MDougados,   PEmery,   E CKeystone,   LKlareskog,   P JMease,  

Preview

3. Why results of clinical trials and observational studies of antitumour necrosis factor (anti-TNF) therapy differ: methodological and interpretive issues
  Annals of the Rheumatic Diseases,   Volume  63,   Issue  suppl_2,   2004,   Page  13-17

FWolfe,   KMichaud,   E MDeWitt,  

Preview

4. Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection
  Annals of the Rheumatic Diseases,   Volume  63,   Issue  suppl_2,   2004,   Page  18-24

L HCalabrese,   NZein,   DVassilopoulos,  

Preview

5. Pharmacogenetics in the rheumatic diseases
  Annals of the Rheumatic Diseases,   Volume  63,   Issue  suppl_2,   2004,   Page  25-27

B NCronstein,  

Preview

6. What precedes development of rheumatoid arthritis?
  Annals of the Rheumatic Diseases,   Volume  63,   Issue  suppl_2,   2004,   Page  28-31

LKlareskog,   LAlfredsson,   SRantapää-Dahlqvist,   EBerglin,   PStolt,   LPadyukov,  

Preview

7. Should contemporary rheumatoid arthritis clinical trials be more like standard patient care and vice versa?
  Annals of the Rheumatic Diseases,   Volume  63,   Issue  suppl_2,   2004,   Page  32-39

TPincus,   TSokka,  

Preview

8. The International Classification of Functioning, Disability and Health (ICF) Core Sets for rheumatoid arthritis: a way to specify functioning
  Annals of the Rheumatic Diseases,   Volume  63,   Issue  suppl_2,   2004,   Page  40-45

GStucki,   ACieza,  

Preview

9. Should infection still be considered as the most likely triggering factor for rheumatoid arthritis?*
  Annals of the Rheumatic Diseases,   Volume  63,   Issue  suppl_2,   2004,   Page  46-49

S MCarty,   NSnowden,   A JSilman,  

Preview

10. New issues in tuberculosis
  Annals of the Rheumatic Diseases,   Volume  63,   Issue  suppl_2,   2004,   Page  50-56

S H EKaufmann,  

Preview

首页 上一页 下一页 尾页 第1页 共21条